Question: is this a 2) strong advice, 1) weak advice 0) no advice?

In patients who had had a recent acute coronary syndrome, dalcetrapib increased HDL cholesterol levels but did not reduce the risk of recurrent cardiovascular events.
user
This is no advice
assistant